112 related articles for article (PubMed ID: 27036195)
1. Heterogeneity in global gene expression profiles between biopsy specimens taken peri-surgically from primary ER-positive breast carcinomas.
López-Knowles E; Gao Q; Cheang MC; Morden J; Parker J; Martin LA; Pinhel I; McNeill F; Hills M; Detre S; Afentakis M; Zabaglo L; Dodson A; Skene A; Holcombe C; Robertson J; Smith I; Bliss JM; Dowsett M;
Breast Cancer Res; 2016 Apr; 18(1):39. PubMed ID: 27036195
[TBL] [Abstract][Full Text] [Related]
2. Comparison of protein expression between formalin-fixed core-cut biopsies and surgical excision specimens using a novel multiplex approach.
Leal MF; Haynes BP; MacNeill FA; Dodson A; Dowsett M
Breast Cancer Res Treat; 2019 Jun; 175(2):317-326. PubMed ID: 30796652
[TBL] [Abstract][Full Text] [Related]
3. An integration of complementary strategies for gene-expression analysis to reveal novel therapeutic opportunities for breast cancer.
Bild AH; Parker JS; Gustafson AM; Acharya CR; Hoadley KA; Anders C; Marcom PK; Carey LA; Potti A; Nevins JR; Perou CM
Breast Cancer Res; 2009; 11(4):R55. PubMed ID: 19638211
[TBL] [Abstract][Full Text] [Related]
4. Intrinsic Subtypes and Gene Expression Profiles in Primary and Metastatic Breast Cancer.
Cejalvo JM; Martínez de Dueñas E; Galván P; García-Recio S; Burgués Gasión O; Paré L; Antolín S; Martinello R; Blancas I; Adamo B; Guerrero-Zotano Á; Muñoz M; Nucíforo P; Vidal M; Pérez RM; Chacón López-Muniz JI; Caballero R; Peg V; Carrasco E; Rojo F; Perou CM; Cortés J; Adamo V; Albanell J; Gomis RR; Lluch A; Prat A
Cancer Res; 2017 May; 77(9):2213-2221. PubMed ID: 28249905
[TBL] [Abstract][Full Text] [Related]
5. Extreme loss of immunoreactive p-Akt and p-Erk1/2 during routine fixation of primary breast cancer.
Pinhel IF; Macneill FA; Hills MJ; Salter J; Detre S; A'hern R; Nerurkar A; Osin P; Smith IE; Dowsett M
Breast Cancer Res; 2010; 12(5):R76. PubMed ID: 20920193
[TBL] [Abstract][Full Text] [Related]
6. Intratumor genetic heterogeneity of breast carcinomas as determined by fine needle aspiration and TaqMan low density array.
Lyng MB; Laenkholm AV; Pallisgaard N; Vach W; Knoop A; Bak M; Ditzel HJ
Cell Oncol; 2007; 29(5):361-72. PubMed ID: 17726259
[TBL] [Abstract][Full Text] [Related]
7. Oncogene protein co-expression. Value of Ha-ras, c-myc, c-fos, and p53 as prognostic discriminants for breast carcinoma.
Bland KI; Konstadoulakis MM; Vezeridis MP; Wanebo HJ
Ann Surg; 1995 Jun; 221(6):706-18; discussion 718-20. PubMed ID: 7794075
[TBL] [Abstract][Full Text] [Related]
8. Molecular subtype profiling of invasive breast cancers weakly positive for estrogen receptor.
Sheffield BS; Kos Z; Asleh-Aburaya K; Wang XQ; Leung S; Gao D; Won J; Chow C; Rachamadugu R; Stijleman I; Wolber R; Gilks CB; Myles N; Thomson T; Hayes MM; Bernard PS; Nielsen TO; Chia SK
Breast Cancer Res Treat; 2016 Feb; 155(3):483-90. PubMed ID: 26846986
[TBL] [Abstract][Full Text] [Related]
9. Novel tumor sampling strategies to enable microarray gene expression signatures in breast cancer: a study to determine feasibility and reproducibility in the context of clinical care.
Tebbit CL; Zhai J; Untch BR; Ellis MJ; Dressman HK; Bentley RC; Baker JA; Marcom PK; Nevins JR; Marks JR; Olson JA
Breast Cancer Res Treat; 2009 Dec; 118(3):635-43. PubMed ID: 19224362
[TBL] [Abstract][Full Text] [Related]
10. Global gene expression changes during neoadjuvant chemotherapy for human breast cancer.
Buchholz TA; Stivers DN; Stec J; Ayers M; Clark E; Bolt A; Sahin AA; Symmans WF; Hess KR; Kuerer HM; Valero V; Hortobagyi GN; Pusztai L
Cancer J; 2002; 8(6):461-8. PubMed ID: 12500855
[TBL] [Abstract][Full Text] [Related]
11. The molecular portraits of breast tumors are conserved across microarray platforms.
Hu Z; Fan C; Oh DS; Marron JS; He X; Qaqish BF; Livasy C; Carey LA; Reynolds E; Dressler L; Nobel A; Parker J; Ewend MG; Sawyer LR; Wu J; Liu Y; Nanda R; Tretiakova M; Ruiz Orrico A; Dreher D; Palazzo JP; Perreard L; Nelson E; Mone M; Hansen H; Mullins M; Quackenbush JF; Ellis MJ; Olopade OI; Bernard PS; Perou CM
BMC Genomics; 2006 Apr; 7():96. PubMed ID: 16643655
[TBL] [Abstract][Full Text] [Related]
12. Expression of C-myc and β-catenin and their correlation in triple negative breast cancer.
Wang J; Li M; Chen D; Nie J; Xi Y; Yang X; Chen Y; Yang Z
Minerva Med; 2017 Dec; 108(6):513-517. PubMed ID: 28889723
[TBL] [Abstract][Full Text] [Related]
13. Association between c-myc amplification and pathological complete response to neoadjuvant chemotherapy in breast cancer.
Yasojima H; Shimomura A; Naoi Y; Kishi K; Baba Y; Shimazu K; Nakayama T; Kim SJ; Tamaki Y; Noguchi S
Eur J Cancer; 2011 Aug; 47(12):1779-88. PubMed ID: 21741827
[TBL] [Abstract][Full Text] [Related]
14. Transfer of clinically relevant gene expression signatures in breast cancer: from Affymetrix microarray to Illumina RNA-Sequencing technology.
Fumagalli D; Blanchet-Cohen A; Brown D; Desmedt C; Gacquer D; Michiels S; Rothé F; Majjaj S; Salgado R; Larsimont D; Ignatiadis M; Maetens M; Piccart M; Detours V; Sotiriou C; Haibe-Kains B
BMC Genomics; 2014 Nov; 15(1):1008. PubMed ID: 25412710
[TBL] [Abstract][Full Text] [Related]
15. Ratio of proliferation markers and HSP90 gene expression as a predictor of pathological complete response in breast cancer neoadjuvant chemotherapy.
Jarzab M; Kowal M; Bal W; Oczko-Wojciechowska M; Rembak-Szynkiewicz J; Kowalska M; Stobiecka E; Chmielik E; Tyszkiewicz T; Kaszuba M; Nowicka E; Lange B; Czarniecka A; Krajewska J; Dyla A; Dobrut M; Lange D; Jarzab B; Bobek-Billewicz B; Tarnawski R
Folia Histochem Cytobiol; 2016; 54(4):202-209. PubMed ID: 28051275
[TBL] [Abstract][Full Text] [Related]
16. Characterization of molecular scores and gene expression signatures in primary breast cancer, local recurrences and brain metastases.
Bustamante Eduardo M; Popovici V; Imboden S; Aebi S; Ballabio N; Altermatt HJ; Günthert A; Jaggi R
BMC Cancer; 2019 Jun; 19(1):549. PubMed ID: 31174485
[TBL] [Abstract][Full Text] [Related]
17. Molecular subtyping of breast cancer intrinsic taxonomy with oligonucleotide microarray and NanoString nCounter.
Chen YJ; Huang CS; Phan NN; Lu TP; Liu CY; Huang CJ; Chiu JH; Tseng LM; Huang CC
Biosci Rep; 2021 Aug; 41(8):. PubMed ID: 34387660
[TBL] [Abstract][Full Text] [Related]
18. Dynamic clonal remodelling in breast cancer metastases is associated with subtype conversion.
Lluch A; González-Angulo AM; Casadevall D; Eterovic AK; Martínez de Dueñas E; Zheng X; Guerrero-Zotano Á; Liu S; Pérez R; Chen K; Chacón JI; Mills GB; Antolín S; Blancas I; López-Serra P; Carrasco E; Caballero R; Prat A; Rojo F; Gonzalez-Perez A; Meric-Bernstam F; Albanell J
Eur J Cancer; 2019 Oct; 120():54-64. PubMed ID: 31491604
[TBL] [Abstract][Full Text] [Related]
19. Gene expression profiles of breast cancer obtained from core cut biopsies before neoadjuvant docetaxel, adriamycin, and cyclophoshamide chemotherapy correlate with routine prognostic markers and could be used to identify predictive signatures.
Rody A; Karn T; Gätje R; Kourtis K; Minckwitz G; Loibl S; Munnes M; Ruckhäberle E; Holtrich U; Kaufmann M; Ahr A
Zentralbl Gynakol; 2006 Apr; 128(2):76-81. PubMed ID: 16673249
[TBL] [Abstract][Full Text] [Related]
20. A high-risk luminal A dominant breast cancer subtype with increased mobility.
Guo L; Chen G; Zhang W; Zhou L; Xiao T; Di X; Wang Y; Feng L; Zhang K
Breast Cancer Res Treat; 2019 Jun; 175(2):459-472. PubMed ID: 30778902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
